Market Overview

Benzinga's Top #PreMarket Gainers

Share:
Related HZNP
Depomed Rejected Horizon Pharma's Takeout Bid, But Still Trades As If M&A Is Happening
Piper Jaffray: Horizon Pharma Still Has Room For Value Creation, Target Hiked To $48
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional ... (GuruFocus)
Related EXAS
Mizuho Reiterates Buy On Exact Sciences, Expects Positive Outcomes On 2 Coming Decisions
Morning Market Losers

Horizon Pharma (NASDAQ: HZNP) surged 20.91% to $17.75 in the pre-market session after the company announced its plans to acquire privately held Vidara Therapeutics International for around $660 million.

Exact Sciences (NASDAQ: EXAS) surged 10.26% to $15.90 in pre-market trading following the published results of colon cancer screening test.

Compugen (NASDAQ: CGEN) shares gained 4.37% to $11.95 in the pre-market after Jefferies initiated coverage on the stock with a Buy rating and a $17.00 price target.

Juniper Networks (NYSE: JNPR) shares jumped 2.51% to $26.56 in pre-market trading after Wells Fargo upgraded the stock from Market Perform to Outperform.

Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers

 

Related Articles (CGEN + EXAS)

Get Benzinga's Newsletters